Skip to main content
Caplight Logo









Ensemo

Ensemo

Private
TullnFrontier & Industrial Techhttps://ensemo.com/

Last Round

Accelerator

Mar 2, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ensemo is an agricultural technology company that has developed a patented technology, SeedJection™, which injects living microorganisms directly into seeds to enhance performance and support plant health with reduced chemical dependence.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Biotech Equipment, Clean Manufacturing

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

biological seed treatmentseed injection technologymicrobial inoculantsagtechagricultural biologicalsag biologicalsseed technologybiotechpre-inoculated seedspesticide alternativefertilizer alternativepay-per-use modelR&D servicessoybean seed treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ensemo Comparables

Compare Ensemo with similar companies based on industry and business-model similarity.

Ensemo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sinochem Holdings Corporation Ltd.
68%
Bayer AG
67%
CropBiome
66%

Ensemo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 2, 2026

Ensemo Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Funding round led by European Innovation Council.

Ensemo Filings

Explore SEC and related filing metadata, where available.

Ensemo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ensemo's valuation, stock price, and market status.

Is Ensemo a public or private company?

Ensemo is a private company.

What is the current stock price of Ensemo?

Ensemo is a private company with no public stock price. No recent secondary market data is available.

How much is Ensemo worth (valuation)?

Valuation information for Ensemo is not publicly available.

Can I buy Ensemo stock?

Ensemo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ensemo's last funding round?

Ensemo's most recent funding round was Accelerator on March 2, 2026.

Who are the main investors in Ensemo?

Key investors in Ensemo include European Innovation Council, Austria Wirtschaftsservice, FFG Austrian Research Promotion Agency.

Will Ensemo IPO soon?

No public IPO plans have been announced for Ensemo.

How can I track Ensemo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ensemo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTulln
Year Founded2021
Last FundingMar 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?